Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-15
1998-11-24
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
058407375
ABSTRACT:
A pharmaceutical composition includes an aqueous solution/suspension of omeprazole or other substituted benzimidazoles and derivatives thereof in a pharmaceutically acceptable carrier comprising a bicarbonate salt of a Group IA metal. A method for treating and/or preventing gastrointestinal conditions by administering to a patient a pharmaceutical composition including an aqueous solution/suspension of omeprazole or other substituted benzimidazoles and derivatives thereof in a pharmaceutically acceptable carrier including a bicarbonate salt of a Group IA metal wherein the administering step consists of a single dosage form without requiring further administering of the bicarbonate salt of the Group IA metal. A pharmaceutical composition for making a solution/suspension of omeprazole or other substituted benzimidazoles and derivatives thereof includes omeprazole or other substituted benzimidazoles and derivatives thereof and a bicarbonate salt of a Group IA metal in a form for convenient storage whereby when the composition is dissolved in aqueous solution, the resulting solution is suitable for enteral administration.
REFERENCES:
patent: 4182766 (1980-01-01), Krasso et al.
patent: 4255431 (1981-03-01), Junggren et al.
patent: 4472409 (1984-09-01), Senn-Bilfinger
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 5219870 (1993-06-01), Kim
patent: 5385739 (1995-01-01), Debregeas et al.
patent: 5391752 (1995-02-01), Hoerrner et al.
patent: 5395323 (1995-03-01), Berglund
patent: 5399700 (1995-03-01), Min et al.
patent: 5417980 (1995-05-01), Goldman et al.
Journal of Clinical Therapeutics & Medicines Nakagawa et al. vol. 7, No. 1, pp. 33-50 Abstract is inclosed, 1991.
Wade, Organic Chemistry, p. 349, Pritice-Hall, Inc, 1987.
The American Midical Association Drug Evaluation, vol. II, Gastrointestinal Drugs; Bennett, DR, Dickson BD (eds.) The American Medical Association, Chicago 1:8. with liver cirrhosis. Clin. Pharmacokinet., 24(1): 71-8.
Andersson et al., (1990) Pharmacokinetics and bioavailability of omerprazole after single and repeated oral administration . . . Br. J. Clin. Pharmacol., 29(5):557-63.
Andersson et al., (1990) Pharmacokinetics of various single intravenous and oral doses of omeprazole. Eur. J. Clin. Pharmacol., 39(2):195-7.
Ballesteros et al., (1990) Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion . . . Ann. Intern. Med., 112:334-339.
Barie and Hariri (1992) Therapeutic use of omeprazole for refractory stress-induced gastric mucosal hemorrhage. Crit. Care Med., 20:899-901.
Bone (1991) Let's agree on terminology: definition of sepsis. Crit. Care Med., 19:27.
Borrero et al., (1986) Antacids vs sucralfate in preventing acute gastrointestinal tract bleeding in abdominal aortic surgery. Arch. Surg., 121:810-812.
Brunton (1990) in The Pharmacologic Basis of Therapeutics. Goodman AG, Rall TW, Nies AS, Taylor P (eds), New York, p. 907.
Cantu and Korek (1991) Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med, 114:1027-1034.
Cioffi et al., (1994) Comparison of acid neutralizing and non-acid neutralizing stress ulcer prophylaxis in thermally injured patients. J. Trauma, 36:541-547.
Cook et al., (1994) Risk factors for gastrointestinal bleeding in critically ill patients. N. Engl. J. Med., 330:377-381.
Cook et al., (1991) Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am. J. Med., 91:519-527.
Cook et al., (1991) Nasocomial pneumonia and the role of gastric pH: a meta-analysis. Chest, 100:7-13.
Czaja et al., (1974) Acute gastroduodenal disease after thermal injury: an endoscopic evaluation of incidence and natural history. N. Engl. J. Med., 291:925-929.
Dobkin et al., (1990) Does pH paper accurately reflect gastic ph? Crit. Care Med., 18:985-988.
Driks et al., (1987) Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N. Engl. J. Med., 317:1376-1382.
Eisenberg et al., (1990) Prospective trial comparing a combination pH probe-nasogastric tube with aspirated gastric pH . . . Crit. Care Med., 18:1092-1095.
Fabian et al., (1993) Pneumonia and stress ulceration in severly injured patients. Arch. Surg., 128:1855.
Fellenius et al. (1981) Substituted benzimidazoles inhibit gastric acid secretion by blocking H+/K+-ATPase. Nature, 290:159-161.
Fiddian-Green et al., (1983) Predictive value of intramural pH and other risk factos for massive bleeding from stress ulceration. Gastroenterology, 8:613-620.
Fryklund et al. (1988) Function and structure of parietal cells after H+/K+-ATPase blockade. Am. J. Physiol, 254 (3 pt 1); G399-407.
Gafter et al., (1989) Thrombocytopenia associated with hypersensitivity to rantidine: possible cross-reactivity . . . Am. J. Gastroenterol., 64:560-562.
Garner et al., (1988) CDC definitions for nosocomial infections. Am. J. Infect. Control., 16:128-140.
Heath et al., (1988) Intragastic pH measurement using a novel disposable sensor. Intens. Care Med., 14:232-235.
Kiilerich et al., (1995) Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastic pH . . . Digestion, 56:25-30.
Laggner et al., (1989) Prevention of upper gastrointestinal bleeding in long-term ventilated patients. Am. J. Med., 86(suppl 6A):81-84.
Landahl et al., (1992) Pharmacokinetic study of omeprazole in elderly healthy volunteers. Clin. Pharmacokinet., Dec:23(6):469-76.
Larson et al., (1984) Gastric response to severe head injury. Am. J. Surg., 147:97-105.
Marrone and Silen, (1984) Pathogenesis, diagnosis and treatment of acute gastric mucosa lesions. Clin. Gastroenterol, 13:635-650.
Martin et al., (1993) Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage . . . Crit. Care Med., 21:19-39.
Martin et al., (1992) Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann. Surg., 215:332-337.
Meiners et al., (1982) Evaluation of various techniques to monitor intragastic pH. Arch. Surg., 117:288-291.
Oh and Carroll (1994) Electrolyte and acid-base disorders. in The Pharmacologic Approach to the Critically Ill Patient. (Chernow B, ed) Williams & Wilkins, Baltimore, pp. 966-967.
Ostro et al. (1985) Control of gastric pH with cimetidine boluses versus primed infusions. Gastroeneterology, 89:532-537.
Peura and Johnson (1985) Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients . . . Ann Intern Med., 103:173-177.
Phillips and Metzler (1994) Simplified omeprazole solution for the prophylaxis of stress-related mucosal damage . . . Crit. Care Med., 22:A53.
Pickworth et al., (1993) Occurrence of nasocomial pneumonia in mechanically ventilated trauma patients . . . Crit. Care Med., 12:1856-1862.
Pilbrant et al. (1985) Development of an oral formulation of omeprazole. Gastroenterol Suppl., 108:113-20.
Priebe and Skillman, (1981) Methods of prophylaxis in stress ulcer disease. World J. Surg., 5:223-233.
Regardh et al., (1990) The pharmacokinetics of omeprazole in humans--a study of single intravenous and oral doses. Ther. Drug Monit., Mar: 12(2):163-72.
Ryan et al., (1993) Nasocomial pneumonia during stress ulcer prophylaxis with cimetidine and sucralfate. Arch. Surg., 128:1353-1357.
Sax (1987) Clinically important adverse effects and drug interactions with H2-receptor antagonists: an update. Pharmacotherapy, 7(6 pt 2): 110S-115S.
Schepp (1993) Stress ulcer prophylaxis: still a valid option in the 1990? Digestion, 54:189-199.
Schuman et al., (1987) Prophylactic therapy for acute ulcer bleeding: a reappraisal. Ann Intern. Med., 106:562-567.
Schuster (1993) Stress ulcer prophylaxis: in whom? with what? Crit. Care Med., 21:4-6.
Siepler (1986) A dosage alternative for H-2 receptor antagonists, continuous-infusion. Clin. Ther., 8(Suppl A):24-33.
Simms et al., (1991) Role of gastric colonizmation in the development of pneumonia in critically ill trauma patients . . . J. Trauma, 31:531-536.
Skillman et al., (1969) Respiratory failure, hypotension, sepsis and jaundice: a clinical syndrome associated with lethal . . . Am. J. Surg.
Fan Jane
The Curators of the University of Missouri
LandOfFree
Omeprazole solution and method for using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Omeprazole solution and method for using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omeprazole solution and method for using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702556